The Evidence Base: New framework proposed for valuing medicines’ broader societal impact

Nov 13

Written by Marshall Bursis

media

Marshall Bursis

Journal of Comparative Effectiveness Research: Generalized cost–effectiveness analysis - charting a path forward for measuring the societal value of medical technologies

R&D World: How much does the pharma industry spend on R&D anyway? Probably more than you thought

/* Autoscroll fix */